Clinical trial data is missing
If a meaningful subset is metabolic OA, driven by insulin resistance and inflammation, then disease modification may require metabolic therapeutics, not just braces and injections
Compare Tesamorelin / Ipamorelin Blend by mechanism, evidence strength, expected timeline, side-effect profile, and whether its primary use case matches your goal
How to read the evidence honestly Not all evidence is the same weight, and a good research reader grades it
Matt Lesser, a Middletown Democrat and co-chair of the Human Services Committee, who sponsored the prescription drug legislation with members of the Bipartisan Drug Task Force, said there are a number of legal and practical questions that the state must address to make a compelling case to the federal government to manufacture the drug